13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q2 2024 · Filed August 9, 2024 · Accession 0001104659-24-087431
Total Value
$949.6M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dyne Therapeutics, Inc. | DYN | 8,020,136 | $283.0M | 29.80% |
| 2 | Kymera Therapeutics, Inc. | KYMR | 5,350,422 | $159.7M | 16.82% |
| 3 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $141.8M | 14.93% |
| 4 | Disc Medicine, Inc. | IRON | 2,509,456 | $113.1M | 11.91% |
| 5 | Day One Biopharmaceuticals, Inc. | DAWN | 6,430,257 | $88.6M | 9.33% |
| 6 | Korro Bio, Inc. | KRRO | 1,137,149 | $38.5M | 4.06% |
| 7 | Q32 Bio, Inc. | QTTB | 2,092,106 | $37.6M | 3.95% |
| 8 | Generation Bio, Co. | 37148K100 | 8,279,484 | $23.3M | 2.46% |
| 9 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $23.3M | 2.46% |
| 10 | Replimune Group, Inc. | REPL | 2,098,300 | $18.9M | 1.99% |
| 11 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $8.3M | 0.87% |
| 12 | Tectonic Therapeutics, Inc. | TECX | 378,447 | $6.2M | 0.66% |
| 13 | Dianthus Therapeutics, Inc. | DNTH | 136,979 | $3.5M | 0.37% |
| 14 | Aerovate Therapeutics, Inc. | 008064107 | 1,799,232 | $3.0M | 0.31% |
| 15 | Spero Therapeutics, Inc. | SPRO | 535,336 | $695,937 | 0.07% |